In the news
US recognises clinical importance of genome sequencing
Comment: This funding allocation is timely, and shows recognition of some of the very important issues and barriers that must be addressed if whole genome sequencing technologies are to be used by hospitals for direct medical benefits, as outlined in the key PHG Foundation report released this autumn, Next steps in the sequence. Other countries should similarly be considering how they will realise this potential; key issues identified in the UK centred on the urgent need to develop bioinformatics expertise and infrastructure for clinical applications, as well as economic and policy analysis. Will the UK government show similar commitment by allocating appropriate funding to such endeavours?